Log In
Print this Print this


Also known as: Atelvia

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionDelayed-release antiresorptive pyridinyl bisphosphonate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat postmenopausal osteoporosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today